why choose us

First received: December 19, 2022

Clinical Trial: Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Refractory Status Epilepticus

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Brief Summary: This project is aiming to better understand the use of perampanel as an appropriate standard-of-care therapy for treatment refractory status epilepticus (RSE), to identify determinants of outcomes, and establish safety.The study will recruit 25 patients at WSU.The study will last for about 96 weeks and will involve a screening visit and two in clinic visits at 3 and 6 months.If the subjects give written informed consent and meet all eligibility criteria they will be clinically evaluated and will be given the study…

Read more